Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Japan flag Japan · Delayed Price · Currency is JPY
5,227.00
-26.00 (-0.49%)
At close: Dec 5, 2025
-13.92%
Market Cap 388.57B
Revenue (ttm) 163.18B
Net Income (ttm) 11.53B
Shares Out 74.34M
EPS (ttm) 155.13
PE Ratio 33.69
Forward PE 29.13
Dividend 104.00 (1.99%)
Ex-Dividend Date Dec 29, 2025
Volume 223,300
Average Volume 235,915
Open 5,260.00
Previous Close 5,253.00
Day's Range 5,225.00 - 5,290.00
52-Week Range 4,850.00 - 6,350.00
Beta 0.27
RSI 46.56
Earnings Date Nov 11, 2025

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling g... [Read more]

Founded 1886
Employees 3,615
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4967
Full Company Profile

Financial Performance

In 2024, Kobayashi Pharmaceutical's revenue was 165.60 billion, a decrease of -4.53% compared to the previous year's 173.46 billion. Earnings were 10.07 billion, a decrease of -50.50%.

Financial Statements

News

There is no news available yet.